Shai Novik

Portfolio · 1

Enlivex Therapeutics

Macrophage Reprogramming Cell Therapies for Life-threatening Diseases

1 round $7.0M committed Latest: 2014-05

Investment activity

1 portfolio exit on record.

Q&A

What is Shai Novik's primary investment focus by sector?

Shai Novik primarily focuses on the Health Tech & Life Sciences sector, with all recorded portfolio companies and exits falling within this area.

Can you name a notable exit for Shai Novik?

In March 2019, Shai Novik had an exit with Enlivex Therapeutics via a Reverse Merger Event, which subsequently listed on NASDAQ.

Which company is a key part of Shai Novik's portfolio?

A key company in Shai Novik's portfolio is Enlivex Therapeutics, which develops macrophage reprogramming cell therapies for life-threatening diseases and has raised $286.9M.

When did Shai Novik make their most recent recorded investment?

Shai Novik's most recent recorded investment activity was in May 2014.

What type of funding stage has Shai Novik participated in?

Shai Novik has participated in Debt Financing rounds.